Conservative Management of Vulvar Cancer-Where Should We Draw the Line?

被引:0
|
作者
Hacker, Neville F. [1 ]
Barlow, Ellen L. [2 ]
机构
[1] Univ New South Wales, Fac Med & Hlth, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia
[2] Univ New South Wales, Fac Med & Hlth, Sch Women & Childrens Hlth, Gynaecol Canc Res Grp, Sydney, NSW 2052, Australia
关键词
vulvar cancer; radical vulvectomy; radical local excision; pelvic lymph node dissection; sentinel node biopsy; surgical margins; ultrasonic groin surveillance; SQUAMOUS-CELL CARCINOMA; PATHOLOGICAL MARGIN DISTANCE; TUMOR-FREE MARGINS; LYMPH-NODE BIOPSY; STAGE-I CARCINOMA; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; LOCAL RECURRENCE; INGUINAL LYMPHADENECTOMY; EPIDERMOID CARCINOMA;
D O I
10.3390/cancers16172991
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vulvar cancer is a rare disease, and cure rates were low until the mid-20th century. The introduction of an en bloc radical vulvectomy and bilateral groin and pelvic lymph node dissection saw them rise from 15-20% to 60-70%. However, this very radical surgery was associated with high physical and psychological morbidity. Wounds were usually left open to granulate, and the average post-operative hospital stay was about 90 days. Many attempts have been made to decrease morbidity without compromising survival. Modifications that have proven to be successful are as follows: (i) the elimination of routine pelvic node dissection, (ii) the use of separate incisions for groin dissection, (iii) the use of unilateral groin dissection for lateral, unifocal lesions, (iv) and radical local excision with 1 cm surgical margins for unifocal lesions. Sentinel node biopsy with ultrasonic groin surveillance for patients with node-negative disease has been the most recent modification and is advocated for patients whose primary cancer is <4 cm in diameter. Controversy currently exists around the need for 1 cm surgical margins around all primary lesions and on the appropriate ultrasonic surveillance for patients with negative sentinel nodes.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [31] The impaired anesthesiologist: where do we draw the line?
    Bryson, Ethan O.
    JOURNAL OF CLINICAL ANESTHESIA, 2010, 22 (05) : 311 - 312
  • [32] Assisted yes, but where do we draw the line?
    Santella, Luigia
    Dale, Brian
    REPRODUCTIVE BIOMEDICINE ONLINE, 2015, 31 (04) : 476 - 478
  • [33] Radiotherapy for small-cell lung cancer-Where are we heading?
    Bayman, N. A.
    Sheikh, H.
    Kularatne, B.
    Lorigan, P.
    Blackhall, F.
    Thatcher, N.
    Faivre-Finn, C.
    LUNG CANCER, 2009, 63 (03) : 307 - 314
  • [34] Early re-resection of high risk non muscle invasive bladder cancer - where should we draw the line?
    Bott, S.
    Mostafid, H.
    BJU INTERNATIONAL, 2008, 101 : 51 - 51
  • [35] Where to Draw the Line? Should the Age of Protection for Zebrafish be Lowered?
    Sneddon, Lynne U.
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2018, 46 (06): : 309 - 311
  • [36] THE HISTORY OF CANCER-WHERE WE ARE AT THE 100TH BIRTHDAY OF THE AMERICAN CANCER SOCIETY
    Elefsiniotis, I. S.
    Tsoumakas, K.
    Kapritsou, M.
    Magaziotou, I
    Derdemezi, A.
    Mariolis-Sapsakos, T.
    Katsoulas, Th
    Konstantinou, E. A.
    GASTROENTEROLOGY NURSING, 2014, 37 (01) : 107 - 107
  • [37] Right vs. Left colorectal cancer - Where do we draw the line?
    Lansom, Joshua
    Liew, Ian
    Ng, Kheng-Seong
    Ly, Theresa
    Naidu, Krishanth
    Chapuis, Pierre
    Chan, Charles
    HUMAN PATHOLOGY, 2024, 151
  • [38] The upper temperature for life - where do we draw the line?
    Cowan, DA
    TRENDS IN MICROBIOLOGY, 2004, 12 (02) : 58 - 60
  • [39] Robust communications or incivility - where do we draw the line?
    Baron, Paula
    Corbin, Lillian
    LEGAL ETHICS, 2015, 18 (01) : 1 - 23
  • [40] The screening of semen donors - where do we draw the line?
    Matson, P
    HUMAN REPRODUCTION, 2001, 16 (10) : 2039 - 2039